Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
Chest
|
June 13, 2015
Prognostication of Mortality in Critically Ill Patients With Severe Infections
Yok-Ai Que, Idris Guessous, Elise Dupuis-Lozeron, et al.
The Journal of Pathology
|
July 31, 2018
Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas
Enrica Saponara, Michele Visentin, Francesco Baschieri, et al.
Human Gene Therapy Methods
|
September 24, 2015
Hepatocyte Transfection in Small Pigs After Weaning by Hydrodynamic Intraportal Injection of Naked DNA/Minicircle Vectors
Fabienne Stoller, Andrea Schlegel, Hiu Man Viecelli, et al.
Nature Biotechnology
|
January 15, 2020
An integrated perfusion machine preserves injured human livers for 1 week
Dilmurodjon Eshmuminov, Dustin Becker, Lucia Bautista Borrego, et al.
Annals of Surgery
|
July 19, 2023
Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver Surgery
Patryk Kambakamba, Marcel A Schneider, Michael Linecker, et al.
FASEB Bioadvances
|
February 12, 2019
Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss
Christoph Tschuor, Ekaterina Kachaylo, Udo Ungethüm, et al.
BMC Cancer
|
October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial
Perparim Limani, Michael Linecker, Philipp Kron, et al.
Science Translational Medicine
|
September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models
Marcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
Diabetes
|
January 1, 2014
Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells
Richard A Zuellig, Thorsten Hornemann, Alaa Othman, et al.
Nature Communications
|
June 22, 2021
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
Marcel A Schneider, Michael Linecker, Ralph Fritsch, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
Chest
|
June 13, 2015
Prognostication of Mortality in Critically Ill Patients With Severe Infections
Yok-Ai Que, Idris Guessous, Elise Dupuis-Lozeron, et al.
The Journal of Pathology
|
July 31, 2018
Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas
Enrica Saponara, Michele Visentin, Francesco Baschieri, et al.
Human Gene Therapy Methods
|
September 24, 2015
Hepatocyte Transfection in Small Pigs After Weaning by Hydrodynamic Intraportal Injection of Naked DNA/Minicircle Vectors
Fabienne Stoller, Andrea Schlegel, Hiu Man Viecelli, et al.
Nature Biotechnology
|
January 15, 2020
An integrated perfusion machine preserves injured human livers for 1 week
Dilmurodjon Eshmuminov, Dustin Becker, Lucia Bautista Borrego, et al.
Annals of Surgery
|
July 19, 2023
Early Postoperative Serum Phosphate Drop Predicts Sufficient Hypertrophy After Liver Surgery
Patryk Kambakamba, Marcel A Schneider, Michael Linecker, et al.
FASEB Bioadvances
|
February 12, 2019
Yes-associated protein promotes early hepatocyte cell cycle progression in regenerating liver after tissue loss
Christoph Tschuor, Ekaterina Kachaylo, Udo Ungethüm, et al.
BMC Cancer
|
October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial
Perparim Limani, Michael Linecker, Philipp Kron, et al.
Science Translational Medicine
|
September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models
Marcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
Diabetes
|
January 1, 2014
Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells
Richard A Zuellig, Thorsten Hornemann, Alaa Othman, et al.
Nature Communications
|
June 22, 2021
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
Marcel A Schneider, Michael Linecker, Ralph Fritsch, et al.
Page
of 18